PLD3 and Alzheimer disease: AD variants or knockdown of PLD3 are associated with dysregulated amyloid precursor protein (APP) processing and a concomitant increase in extracellular Aβ levels whereas PLD3 overexpression decreases levels of both [1, 5, 6].